NASDAQ: TLX
Telix Pharmaceuticals Ltd Stock Ownership - Who owns Telix Pharmaceuticals?

Insider buying vs selling

Have Telix Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christian BehrenbruchMD Group CEO2026-04-2933,435$14.87
$497.18kBuy
Christian BehrenbruchMD Group CEO2026-04-2834,500$14.48
$499.56kBuy

1 of 1

TLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLX insiders and whales buy or sell their stock.

TLX Shareholders

What type of owners hold Telix Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christian Behrenbruch6.20%20,996,941$213.96MInsider
Mark Alexander Nelson1.07%3,628,750$36.98MInsider
Jann Elizabeth Skinner0.18%595,000$6.06MInsider
Fmr LLC0.17%564,757$5.75MInstitution
Portolan Capital Management LLC0.16%541,267$5.52MInstitution
David Norman Cade0.11%373,133$3.80MInsider
Lazard Asset Management LLC0.09%289,917$2.95MInstitution
Portland Investment Counsel Inc0.08%266,200$2.71MInstitution
Private Advisor Group LLC0.05%174,415$1.78MInstitution
Integrated Wealth Concepts LLC0.05%164,397$1.68MInstitution

1 of 3

TLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLX0.76%7.56%Net Buying
ALMS77.17%22.83%Net BuyingNet Buying
GPCR31.31%10.35%Net SellingNet Buying
ARQT77.49%22.51%Net SellingNet Selling
LEGN25.86%0.15%Net SellingNet Selling

Telix Pharmaceuticals Stock Ownership FAQ

Who owns Telix Pharmaceuticals?

Telix Pharmaceuticals (NASDAQ: TLX) is owned by 0.76% institutional shareholders, 7.56% Telix Pharmaceuticals insiders, and 91.68% retail investors. Christian Behrenbruch is the largest individual Telix Pharmaceuticals shareholder, owning 21.00M shares representing 6.20% of the company. Christian Behrenbruch's Telix Pharmaceuticals shares are currently valued at $212.07M.

If you're new to stock investing, here's how to buy Telix Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.